Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Sosei to Receive Grant from NEDO’s FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions

August 22, 2011 By Bio-Medicine.Org

TOKYO, August 22, 2011 /PRNewswire/ —

?

Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565),
announces that its wholly owned subsidiary Activus Pharma Co., Ltd.
(“Activus”) is to receive a grant for its “Development of
Innovative Ophthalmic Solutions” from the New Energy and Industrial
Technology Development Organization (NEDO), an Incorporated
Administrative Agency under the Ministry of Economy, Trade and
Industry (METI) as a part of their FY2011 Innovation Promotion
Programme.

The grant is awarded to private sector companies that focus on
development of advanced technologies with practical application,
and is intended to enhance the global competitiveness of Japanese
companies, as well as to promote development of new industries.

Using Activus Pure Nano-particle Technology (APNT) and
surface-modified nanoparticle technology, Activus is focusing on
development of high value-added products that would solve the
problems existing formulations are facing. To explore the potential
of APNT in treatment of ophthalmic diseases, Activus has signed a
collaboration agreement with Professor Hifofumi Takeuchi
(Pharmaceutical Engineering Laboratory) and Professor Hideaki Hara
(Laboratory of Molecular Pharmacology) of Gifu Pharmaceutical
University and is now working on the development of novel posterior
eye segment medication. Posterior eye segment disease such as
diabetic retinopathy and age-related maculopathy is the primary
cause of blindness and other visual impairments in middle age. An
effective and easy-to-use medication has still not been invented,
and the development of an innovative treatment is anticipated.

Within this subsidized project, Activus will be working on the
development of novel ophthalmic solutions that would differ from
the existing treatments because they would be delivered to the
posterior eye segment. In that way, Activus would contribute to the
QOL improvement in patients with visual impairments.

Up

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech